News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,904 Results
Type
Article (62472)
Company Profile (95)
Press Release (669322)
Multimedia
Podcasts (167)
Webinars (27)
Section
Business (198696)
Career Advice (3029)
Deals (34775)
Drug Delivery (138)
Drug Development (81404)
Employer Resources (176)
FDA (16353)
Job Trends (15135)
News (340363)
Policy (32838)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2854)
Academic (2)
Accelerated approval (41)
Adcomms (32)
Allergies (167)
Alliances (49940)
ALS (198)
Alzheimer's disease (1767)
Antibody-drug conjugate (ADC) (373)
Approvals (16660)
Artificial intelligence (658)
Autoimmune disease (234)
Automation (50)
Bankruptcy (316)
Best Places to Work (11609)
BIOSECURE Act (20)
Biosimilars (206)
Biotechnology (69)
Bladder cancer (179)
Brain cancer (70)
Breast cancer (696)
Cancer (5396)
Cardiovascular disease (464)
Career advice (2588)
Career pathing (45)
CAR-T (318)
CDC (60)
Celiac Disease (2)
Cell therapy (860)
Cervical cancer (42)
Clinical research (69993)
Collaboration (1962)
Company closure (7)
Compensation (894)
Complete response letters (76)
COVID-19 (2805)
CRISPR (106)
C-suite (1046)
Cystic fibrosis (153)
Data (7095)
Decentralized trials (3)
Denatured (59)
Depression (156)
Dermatology (54)
Diabetes (552)
Diagnostics (6894)
Digital health (53)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (321)
Drug pricing (212)
Drug shortages (30)
Duchenne muscular dystrophy (260)
Earnings (80603)
Editorial (68)
Employer branding (21)
Employer resources (157)
Events (113001)
Executive appointments (1101)
FDA (19856)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (30)
Funding (1651)
Gene editing (222)
Generative AI (69)
Gene therapy (677)
GLP-1 (1056)
Government (5070)
Grass and pollen (8)
Guidances (396)
Healthcare (19229)
HIV (75)
Huntington's disease (50)
IgA nephropathy (88)
Immunology and inflammation (268)
Immuno-oncology (82)
Indications (155)
Infectious disease (3122)
Inflammatory bowel disease (211)
Inflation Reduction Act (16)
Influenza (132)
Intellectual property (277)
Interviews (577)
IPO (15967)
IRA (52)
Job creations (3861)
Job search strategy (2128)
JPM (67)
Kidney cancer (19)
Labor market (89)
Layoffs (629)
Leadership (43)
Legal (7855)
Liver cancer (98)
Longevity (25)
Lung cancer (721)
Lymphoma (406)
Machine learning (51)
Management (59)
Manufacturing (926)
MASH (183)
Medical device (13747)
Medtech (13824)
Mergers & acquisitions (20025)
Metabolic disorders (1444)
mRNA (193)
Multiple sclerosis (171)
NASH (19)
Neurodegenerative disease (386)
Neuropsychiatric disorders (100)
Neuroscience (3173)
Neurotech (1)
NextGen: Class of 2026 (6792)
Non-profit (4716)
Now hiring (31)
Obesity (674)
Opinion (337)
Ovarian cancer (185)
Pain (236)
Pancreatic cancer (257)
Parkinson's disease (341)
Partnered (36)
Patents (568)
Patient recruitment (614)
Peanut (64)
People (62747)
Pharmaceutical (21)
Pharmacy benefit managers (31)
Phase 1 (21878)
Phase 2 (30715)
Phase 3 (22809)
Pipeline (7115)
Policy (325)
Postmarket research (2776)
Preclinical (9380)
Press Release (68)
Prostate cancer (284)
Psychedelics (48)
Radiopharmaceuticals (315)
Rare diseases (1020)
Real estate (6363)
Recruiting (75)
Regulatory (24946)
Reports (52)
Research institute (2630)
Resumes & cover letters (465)
Rett syndrome (33)
RNA editing (18)
RSV (83)
Schizophrenia (166)
Series A (283)
Series B (195)
Service/supplier (9)
Sickle cell disease (107)
Special edition (22)
Spinal muscular atrophy (171)
Sponsored (48)
Startups (3561)
State (1)
Stomach cancer (16)
Supply chain (116)
Tariffs (77)
The Weekly (105)
Vaccines (1107)
Venture capital (93)
Weight loss (437)
Women's health (105)
Worklife (23)
Date
Last 7 days (631)
Last 30 days (2460)
Last 365 days (30046)
2026 (8032)
2025 (30386)
2024 (34370)
2023 (38733)
2022 (49497)
2021 (54622)
2020 (53634)
2019 (47440)
2018 (36007)
2017 (32983)
2016 (32808)
2015 (38413)
2014 (32114)
2013 (28446)
2012 (29712)
2011 (29558)
2010 (28292)
Location
Africa (997)
Alabama (96)
Alaska (7)
Arizona (277)
Arkansas (15)
Asia (42865)
Australia (7555)
California (11685)
Canada (3456)
China (1249)
Colorado (523)
Connecticut (530)
Delaware (366)
Europe (99472)
Florida (1788)
Georgia (403)
Hawaii (3)
Idaho (62)
Illinois (988)
India (84)
Indiana (559)
Iowa (20)
Japan (477)
Kansas (127)
Kentucky (47)
Louisiana (40)
Maine (78)
Maryland (1441)
Massachusetts (8451)
Michigan (362)
Minnesota (647)
Mississippi (7)
Missouri (149)
Montana (36)
Nebraska (26)
Nevada (131)
New Hampshire (82)
New Jersey (3295)
New Mexico (32)
New York (3232)
North Carolina (1558)
North Dakota (9)
Northern California (5704)
Ohio (358)
Oklahoma (25)
Oregon (41)
Pennsylvania (2362)
Puerto Rico (25)
Rhode Island (46)
South America (1331)
South Carolina (67)
South Dakota (1)
Southern California (4673)
Tennessee (199)
Texas (1907)
United States (42398)
Utah (373)
Vermont (1)
Virginia (287)
Washington D.C. (76)
Washington State (953)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
731,904 Results for "institute of bioengineering and nanotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines
April 3, 2026
·
3 min read
Press Releases
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
March 27, 2026
·
4 min read
Press Releases
Auragens Officially Launches Dedicated Orthobiologics Division, A First in the Field by a Regenerative Medicine and Research Institute
March 10, 2026
·
3 min read
Press Releases
23andMe Research Institute Appoints John McLeod General Counsel and Chief Risk Officer
December 10, 2025
·
2 min read
Press Releases
23andMe Research Institute Appoints Kael Reicin as Chief Financial Officer
November 6, 2025
·
2 min read
Press Releases
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
March 23, 2026
·
4 min read
Press Releases
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
February 25, 2026
·
3 min read
Press Releases
Panoramic Health and West Coast Kidney Institute Launch Concord Cardio-Renal Research Institute to Advance Clinical Trials in Cardio-Renal-Metabolic Disease
April 2, 2026
·
3 min read
Press Releases
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
September 30, 2025
·
7 min read
Press Releases
Regenerative Patch Technologies (RPT) Announces Treatment of First Two Patients in Phase IIb Clinical Trial Assessing the Safety and Efficacy of its Allogeneic Bioengineered RPE Cell Implant for the Treatment of Advanced Dry Age-Related Macular Degeneration.
December 10, 2025
·
4 min read
1 of 73,191
Next
